Related Experiment Video
Updated: Jul 27, 2026
10:42
Bioluminescence Imaging of NADPH Oxidase Activity in Different Animal Models
Published on: October 22, 2012
16.2K
Molybdenum Nanoparticles Alleviate MC903-Induced Atopic Dermatitis-Like Symptoms in Mice by Modulating the
Qin Xiao1, Jing Guo1, Yongzhou Lu1
1Department of Dermatology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
International Journal of Nanomedicine
|September 2, 2024
Summary
Molybdenum nanoparticles (Mo NPs) effectively treat atopic dermatitis (AD) by reducing inflammation and oxidative stress. This study shows Mo NPs alleviate AD symptoms and repair skin barriers in a mouse model.
Area of Science:
- Dermatology
- Nanotechnology
- Biochemistry
Background:
- Atopic dermatitis (AD) is a chronic inflammatory skin condition.
- Oxidative stress is a key factor in AD development.
- Nano-molybdenum shows potential as an antioxidant therapy.
Purpose of the Study:
- To evaluate the therapeutic effects of molybdenum nanoparticles (Mo NPs) on AD.
- To investigate the preliminary mechanisms of Mo NPs in a murine model of AD-like disease.
Main Methods:
- HaCaT cells were used to assess Mo NP effects on inflammatory markers and pathways.
- A mouse model of chemically induced AD-like disease was treated with topical Mo NPs.
- Evaluated dermatitis and pruritus scores, skin barrier function, and inflammatory markers.
Main Results:
- Topical Mo NPs significantly reduced AD skin lesions, itching, and improved skin barrier repair.
- Mo NPs inhibited the nuclear factor kappa-B pathway and suppressed oxidative stress.
- Mo NPs reduced inflammatory factors, chemokines, and thymic stromal lymphopoietin expression.
Conclusions:
- Mo NPs offer a promising therapeutic option for atopic dermatitis.
- Mo NPs concurrently target multiple key mechanisms in AD pathogenesis.
- This suggests a novel approach for managing AD symptoms and underlying causes.
